Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04163458 · ClinicalTrials.gov registry record · Phase 3
Comparison of MENOPUR Liquid and Powder in Women Undergoing Assisted Reproductive Technology (ART)
A Phase 3 study of Infertility, sponsored by Ferring Pharmaceuticals.
- Completed
- Registry status
- Phase 3
- Development phase
- 405
- Enrollment target
- 20
- Study locations
NCT04163458: Completed Phase 3 study of Infertility, sponsored by Ferring Pharmaceuticals.
NCT04163458 is a Phase 3 study of Infertility that has completed, run by Ferring Pharmaceuticals. The registered enrollment target is 405 participants, below the 7,584-participant average among 74 other Infertility trials with a reported enrollment target (95% lower). The trial reports 20 study locations across 14 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04163458, a Phase 3 study of Infertility, has completed, sponsored by Ferring Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 405 participants
- Enrollment target
- 20
- Study locations
Study Summary
Development of multiple follicles and pregnancy in ovulatory women undergoing controlled ovarian stimulation as part of an assisted reproductive technology (ART) cycle.
Primary Outcome
Fertilized oocytes with 2PN were regarded as correctly fertilized.
Conditions Studied
Interventions
- DRUG MENOPUR solution for injection in pre-filled pen, 1200 IU/1.92 mL
- DRUG MENOPUR powder and solvent for solution for injection, 75 IU
- OTHER Placebo (for MENOPUR solution for injection in pre-filled pen)
- OTHER Placebo (for MENOPUR powder and solvent for solution for injection)
Study Locations (20)
Texas
- Center for Assisted Reproduction - Bedford
- Houston Fertility Institute - Houston
- Center of Reproductive Medicine - Webster
Connecticut
- Center for Advanced Reproductive Services PC - Farmington
- Yale Fertility Center - New Haven
Florida
- Fertility and IVF Center of Miami - Miami
- Center for Reproductive Medicine - Winter Park
Illinois
- Fertility Centers of Illinois - Chicago
- InVia Fertility Specialists, SC - Hoffman Estates
North Carolina
- Reproductive Endocrinology Associates of Charlotte - Charlotte
- Carolina Conceptions - Raleigh
Arizona
- Fertility Treatment Center - Tempe
California
- Fertility Specialists Medical Group - San Diego Center for Reproductive Surgery - San Diego
Idaho
- Idaho Center for Reproductive Medicine - Boise
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 405 participants |
| Start Date | 2019-10-25 |
| Est. Completion | 2021-07-16 |
| Phase | Phase 3 |
What the finished NCT04163458 record still lists
NCT04163458 is an interventional study that assigns participants to a tested intervention. The registered 405 participants enrollment target is mid-sized for trials with a published cap, below the 7,584-participant average among 74 other Infertility trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Infertility appearing as the primary indexed condition, and to 4 interventions - of which MENOPUR solution for injection in pre-filled pen, 1200 IU/1.92 mL is the first listed.
NCT04163458 names 20 study sites across 14 states, led by Texas, Connecticut, Florida.
Frequently Asked Questions
What is clinical trial NCT04163458 about?
NCT04163458 is a clinical study titled "Comparison of MENOPUR Liquid and Powder in Women Undergoing Assisted Reproductive Technology (ART)". Development of multiple follicles and pregnancy in ovulatory women undergoing controlled ovarian stimulation as part of an assisted reproductive technology (ART) cycle.
What is the current status of trial NCT04163458?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 405 participants. The study started on 2019-10-25. Estimated completion is 2021-07-16.
What conditions does trial NCT04163458 study?
This clinical trial studies the following conditions: Infertility.
What interventions are being tested in trial NCT04163458?
The interventions under investigation include: MENOPUR solution for injection in pre-filled pen, 1200 IU/1.92 mL (DRUG), MENOPUR powder and solvent for solution for injection, 75 IU (DRUG), Placebo (for MENOPUR solution for injection in pre-filled pen) (OTHER), Placebo (for MENOPUR powder and solvent for solution for injection) (OTHER).
Who is sponsoring clinical trial NCT04163458?
This trial is sponsored by Ferring Pharmaceuticals, which has 83 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04163458 being conducted?
This trial has 20 study locations across Arizona, California, Connecticut, Florida, Idaho. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Infertility
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04163458's enrollment target sits among peer trials
405 28th of 74 higher than 47 of 74 other Infertility trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Infertility trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Pre-IVF Treatment With a GnRH Antagonist in Women With endometriosis_temp
RECRUITING · Phase 3
-
Fertility Preservation Using Tamoxifen and Letrozole in Estrogen Sensitive Tumors Trial
RECRUITING · Phase 3
-
Subcutaneous Progesterone in Frozen- Thawed Single Euploid Blastocyst Transfer.
ACTIVE NOT RECRUITING · Phase 3
-
Vaginal Culture Using INVOcell Compared to Traditional IVF Incubation
COMPLETED · Phase 3
-
A Clinical Trial to Evaluate the Efficacy and Safety of DR-2011 for In Vitro Fertilization
COMPLETED · Phase 3
-
Gamete Treatment to Correct Fertilization Failure
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05576350 · 405 participants · NA
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
- NCT07066657 · 405 participants · Phase 1
A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
- NCT06223360 · 406 participants · Phase 2
A Trial to Evaluate the Safety and Efficacy of Benfotiamine in Patients With Early Alzheimer's Disease (BenfoTeam)
- NCT06411769 · 406 participants · NA
Evidence-based Intervention to Improve Walking Engagement in El Paso, Texas
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI